advertisement

---

Lafuma A 3

Showing records 1 to 3 | Display all abstracts from Lafuma A

24647 Treatment persistency of xalatan-xalacom, lumigan ganfort and travatan-duotrav: An analysis conducted on the United-Kingdom general practitioner research database
Berdeaux G; Lafuma A; Robert J
Value in Health 2009; 12: A452

---

24655 A french economic model comparing cost-effectiveness of duotrav and xalacom in Glaucoma
Lafuma A; Laurendeau C; Berdeaux G
Value in Health 2009; 12: A455

---

24650 Interventional procedures in glaucoma: resources and costs in five european countries
Lafuma A; Verboven Y; Darba J; Brueggenjuergen B; Gylee E; Berto P
Value in Health 2009; 12: A460

---